| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |